AskDoctor
☰
← Back to Los Angeles Doctors
Photo of YOURAM NASSIR, Myelofibrosis, Polycythemia Rubra Vera, Bone Marrow Transplant, Flu (Human Influenza), Leukemia, Anemia, Hematology, Myeloma, Deep Vein Thrombosis (DVT), Non-Small-Cell Lung, Head and Neck Cancer, Leukocytosis & Lymphoma Cancer Treatment in LOS ANGELES
β˜… 4.1 (119 reviews)

YOURAM NASSIR MD

Myelofibrosis, Polycythemia Rubra Vera, Bone Marrow Transplant, Flu (Human Influenza), Leukemia, Anemia, Hematology, Myeloma, Deep Vein Thrombosis (DVT), Non-Small-Cell Lung, Head and Neck Cancer, Leukocytosis & Lymphoma Cancer Treatment in Los Angeles

Clinic: CANCER CARE INSTITUTE

Address: πŸ—ΊοΈ 5901 West Olympic Boulevard, Suite 505, Los Angeles, CA 90036

Phone: +1-323-930-2324

Email: drnassir@cancer-care-institute.com

Website: Visit Website

Insurance Accepted: Aetna, Blue Cross Blue Shield of California, Blue Shield of California, Buckeye Community Health Plan, Cigna, LACare, Medi-Cal & Medicare

Experience: Since 1996

Available Timing

About YOURAM NASSIR

Meet Dr. Youram Nassir, a distinguished oncologist renowned in Los Angeles, CA, for his expertise in treating acute and chronic diseases in adults. He is a Board Certified Medical Oncologist with a wealth of experience in hematology-oncology. Dr. Nassir completed his undergraduate studies at the University of Toronto, Canada, majoring in Biology from 1987 to 1989. He then pursued his Internship and Residency at the University of California, refining his skills further. Dr. Nassir is currently associated with esteemed medical institutions like USC Medical Center, Cedars Sinai Medical Center, and Olympia Medical Center. His multilingual capabilities in Farsi, Russian, and Spanish facilitate effective communication with diverse patient groups, contributing to personalized cancer care at the Cancer Care Institute, where he plays a valuable role. Noteworthy points about Dr. Nassir include his over twenty years of experience, expertise in the evolving landscape of cancer care, and proficiency in accessing targeted therapies.